Office Action Predictor
Last updated: April 15, 2026
Application No. 18/414,202

HANDHELD SURGICAL INSTRUMENT

Non-Final OA §102§103§112
Filed
Jan 16, 2024
Examiner
GUPTA, ANANT AGUILAR
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Olympus Winter & Ibe GMBH
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
3y 0m
To Grant
88%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allow Rate
160 granted / 214 resolved
+4.8% vs TC avg
Moderate +13% lift
Without
With
+12.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
29 currently pending
Career history
243
Total Applications
across all art units

Statute-Specific Performance

§101
6.7%
-33.3% vs TC avg
§103
42.1%
+2.1% vs TC avg
§102
16.6%
-23.4% vs TC avg
§112
22.1%
-17.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 214 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-5 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claim 1, ll. 2-5 recites, “… a first component by which an opening in a second component of the instrument can be covered or closed…”. The use of the term “can be” renders the claim indefinite because it implies the limitations following are optional, i.e., the limitations “can be” present but does not necessarily have to be present. For examination purposes, this limitation has been interpreted as “… a first component by which an opening in a second component of the instrument is covered or closed…”. As a result of dependence on claim 1, subsequent dependent claims 2-5 are also rejected as indefinite. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim 1 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Rosenbaum et al. (US 2018/0344427) (hereinafter Rosenbaum). Regarding claim 1, Rosenbaum discloses a handheld surgical instrument (Abstract discloses trocar; Figs. 12-13 show trocar in different working positions) having a first component (scope 56) by which an opening in a second component (cannula 42 with opening 54) of the instrument is covered or closed (scope 56 covers opening 54 in Fig. 12), the first and second components being movable relative to each other (Figs. 12-13 show how scope 56 is movable relative to cannula 40), wherein a structural element made from a shape-memory material is arranged between these two components in order to produce a temperature-dependent relative arrangement of the two components (cleaning element 60; para. 59: “Cleaning element 60 may include a suitable biasing element, such as a spring or other device (e.g., a shape memory metal), to urge cleaning element 60 to return to the first position substantially covering second opening 54 when scope 56 is retracted proximally into access channel 50”). Claims 6 and 10 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Hegeman et al. (US 2007/0250113) (hereinafter Hegeman). Regarding claim 6, Hegeman discloses a handheld surgical instrument (Abstract; Figs. 3-4) having a first component and a second component (individual jaws of end effector 102), the two components being movable relative to each other so that the instrument can be brought into different working positions (Figs. 3-4 depict how jaws are movable relative to each other to open and close), wherein the two components are mechanically coupled to each other by a structural element made from a shape- memory material (rod 125; para. 85: “In some embodiments, the movable tension bearing member or rod may comprise any flexible tension bearing material; in some embodiments Nitinol offers particular advantages as it is sufficiently flexible to accommodate articulation, and yet resilient enough to carry a compressive load that allows the rod to open an end effector, such as a set of jaws”). Regarding claim 10, Hegeman discloses the shape-memory material is nitinol (para. 85). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim 2 is rejected under 35 U.S.C. 103 as being unpatentable over Rosenbaum in view of Houser et al. (US 2015/0351792) (hereinafter Houser). Regarding claim 2, Rosenbaum does not disclose this structural element is a wave spring. Houser, however, teaches a handheld surgical instrument (Fig. 1’) wherein a force limiting spring 155 is described in the art as a wave spring, due to the shape of the spring elements 159. It is advantageous to use a wave spring for force limiting spring 155 because it provides a high spring rate in a small physical size well suited to a surgical instrument (para. 51). It would have been obvious to one of ordinary skill in the art before the effective filing date of this invention to modify Rosenbaum such that the structural element is a wave spring. Making this modification would be useful for providing a high spring rate in a small physical size well suited to a surgical instrument, as taught by Houser. Claim 5 is rejected under 35 U.S.C. 103 as being unpatentable over Rosenbaum in view of Nitinol NPL (https://customwiretech.com/2021/07/the-nitinol-advantage/). Regarding claim 5, Rosenbaum does not teach the shape-memory material is nitinol. Nitinol NPL, however, teaches that nitinol is an especially valuable alloy because it is extremely elastic and can change shape depending on temperature. Nitinol NPL also teaches nitinol is an excellent material to use when creating components for minimally invasive medical devices (under “Nitinol’s Unique Properties”). It would have been obvious to one of ordinary skill in the art before the effective filing date of this invention to modify Rosenbaum such that the shape-memory material is nitinol because it is extremely elastic, can change shape depending on temperature, and nitinol is an excellent material to use when creating components for minimally invasive medical devices, as taught by Nitinol NPL. Claim 7 is rejected under 35 U.S.C. 103 as being unpatentable over Hegeman in view of Keating et al. (US 2013/0030462) (hereinafter Keating). Regarding claim 7, Hegeman does not disclose this structural element is a spring. Keating, however, teaches a laparoscopic surgical device comprising a pair of jaws (Abstract) wherein a shape memory spring material would be useful in embodiments which employ springs disposed between the jaws 115 and 116 to enable a larger opening without permanent deformation occurring. The spring component may also be placed in series (longitudinally) or in parallel (vertically) to achieve greater closure forces (para. 152). It would have been obvious to one of ordinary skill in the art before the effective filing date of this invention to modify Hegeman such that the structural element is a spring. Making this modification would be useful for enabling a larger opening without permanent deformation occurring and achieving greater closure forces, as taught by Keating. Allowable Subject Matter Claims 3-4 and 8-9 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Benecke (US 5665050) discloses a handheld surgical instrument comprising a superelastic-alloy force transmitting element (Abstract) such as nitinol (Col. 1, ll. 11-12). Any inquiry concerning this communication or earlier communications from the examiner should be directed to Anant A Gupta whose telephone number is (571)272-8088. The examiner can normally be reached Mon-Fri 9 am - 5 pm ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niketa Patel can be reached at (571) 272-4156. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /A.A.G./Examiner, Art Unit 3792 /NIKETA PATEL/Supervisory Patent Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Jan 16, 2024
Application Filed
Dec 22, 2025
Non-Final Rejection — §102, §103, §112
Mar 27, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594040
BAYESIAN FRAMEWORK FOR PERSONALIZED MODEL IDENTIFICATION AND PREDICTION OF FUTURE BLOOD GLUCOSE IN TYPE 1 DIABETES USING EASILY ACCESSIBLE PATIENT DATA
2y 5m to grant Granted Apr 07, 2026
Patent 12589242
ELECTRICAL STIMULATION-BASED ANKLE MUSCLE REHABILITATION TRAINING APPARATUS AND CONTROL METHOD THEREOF
2y 5m to grant Granted Mar 31, 2026
Patent 12576266
CRANIAL IMPLANT WITH WIRE MANAGEMENT STRUCTURE
2y 5m to grant Granted Mar 17, 2026
Patent 12564711
METHOD AND DEVICE FOR MANAGING PROCESSING ACTIVITY PATTERNS
2y 5m to grant Granted Mar 03, 2026
Patent 12551205
MEDICAL ARTICULATION DEVICES AND METHODS OF USING THE SAME
2y 5m to grant Granted Feb 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
88%
With Interview (+12.7%)
3y 0m
Median Time to Grant
Low
PTA Risk
Based on 214 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month